Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.
Farolfi A, Petracci E, Gurioli G, Tedaldi G, Casanova C, Arcangeli V, Amadori A, Rosati M, Stefanetti M, Burgio SL, Cursano MC, Lolli C, Zampiga V, Cangini I, Schepisi G, De Giorgi U. Farolfi A, et al. Among authors: burgio sl. Front Oncol. 2023 Aug 16;13:1221096. doi: 10.3389/fonc.2023.1221096. eCollection 2023. Front Oncol. 2023. PMID: 37664032 Free PMC article.
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.
Conteduca V, Scarpi E, Farolfi A, Brighi N, Rossi L, Gurioli G, Lolli C, Schepisi G, Bleve S, Gianni C, Virga A, Altavilla A, Burgio SL, Menna C, De Giorgi U. Conteduca V, et al. Among authors: burgio sl. Front Oncol. 2021 Jul 21;11:716467. doi: 10.3389/fonc.2021.716467. eCollection 2021. Front Oncol. 2021. PMID: 34367999 Free PMC article.
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer.
Conteduca V, Gurioli G, Rossi L, Scarpi E, Lolli C, Schepisi G, Farolfi A, De Lisi D, Gallà V, Burgio SL, Menna C, Amadori A, Losi L, Amadori D, Costi MP, De Giorgi U. Conteduca V, et al. Among authors: burgio sl. BMC Cancer. 2018 Dec 19;18(1):1267. doi: 10.1186/s12885-018-5180-1. BMC Cancer. 2018. PMID: 30567527 Free PMC article.
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors.
Schepisi G, Brighi N, Cursano MC, Gurioli G, Ravaglia G, Altavilla A, Burgio SL, Testoni S, Menna C, Farolfi A, Casadei C, Tonini G, Santini D, De Giorgi U. Schepisi G, et al. Among authors: burgio sl. J Oncol. 2019 Sep 19;2019:7317964. doi: 10.1155/2019/7317964. eCollection 2019. J Oncol. 2019. PMID: 31641355 Free PMC article. Review.
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors.
Schepisi G, Conteduca V, Casadei C, Gurioli G, Rossi L, Gallà V, Cursano MC, Brighi N, Lolli C, Menna C, Farolfi A, Burgio SL, Altavilla A, Martinelli G, De Giorgi U. Schepisi G, et al. Among authors: burgio sl. Front Oncol. 2020 Sep 23;10:565857. doi: 10.3389/fonc.2020.565857. eCollection 2020. Front Oncol. 2020. PMID: 33072597 Free PMC article. Review.
Association among metabolic syndrome, inflammation, and survival in prostate cancer.
Conteduca V, Caffo O, Galli L, Maugeri A, Scarpi E, Maines F, Chiuri VE, Lolli C, Kinspergher S, Schepisi G, Santoni M, Santini D, Fratino L, Burgio SL, Salvi S, Menna C, De Giorgi U. Conteduca V, et al. Among authors: burgio sl. Urol Oncol. 2018 May;36(5):240.e1-240.e11. doi: 10.1016/j.urolonc.2018.01.007. Epub 2018 Mar 2. Urol Oncol. 2018. PMID: 29402534
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer.
Conteduca V, Scarpi E, Salvi S, Casadio V, Lolli C, Gurioli G, Schepisi G, Wetterskog D, Farolfi A, Menna C, De Lisi D, Burgio SL, Beltran H, Attard G, De Giorgi U. Conteduca V, et al. Among authors: burgio sl. Sci Rep. 2018 Oct 18;8(1):15442. doi: 10.1038/s41598-018-33774-4. Sci Rep. 2018. PMID: 30337589 Free PMC article.
Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support.
De Padova S, Casadei C, Berardi A, Bertelli T, Filograna A, Cursano MC, Menna C, Burgio SL, Altavilla A, Schepisi G, Prati S, Montalti S, Chovanec M, Banna GL, Grassi L, Mego M, De Giorgi U. De Padova S, et al. Among authors: burgio sl. Front Endocrinol (Lausanne). 2019 May 28;10:318. doi: 10.3389/fendo.2019.00318. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31191451 Free PMC article. Review.
37 results